Pathology of germ cell tumors of the testis

Cancer Control

Volumn 11, Issue 6, 2004, Pages 374-387

  Sesterhenn, Isabell A ^a   Davis, Charles J ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; CANCER CLASSIFICATION; CANCER STAGING; CELL TYPE; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE MARKER; GERM CELL TUMOR; HISTOLOGY; HUMAN; MALE; REVIEW; TESTIS TUMOR;

EID: 10044219520     PISSN: 10732748     EISSN: None     Source Type: Journal    
DOI: 10.1177/107327480401100605     Document Type: Review

References (85)

1. Coleman MP, Esteve J, Damiecki P, et al. Trends in cancer incidence and mortality. IARC Sci Publ. 1993;121:1-806.
2. Eble JN, Sauter G, Epstein JI, Sesterhenn I. WHO Classification of Tumours. Pathology and Genetics. Tumours of the Urinary System and Male Genital Organs. Lyon, France: IARC Press; 2004.
3. Mostofi FK, Sesterhenn IA. Histological Typing of Testis Tumors. 2nd ed. World Health Organization. Springer-Verlag: Berlin Heidelberg; 1998.
4. Sobin LH, Wittekind C, eds. TNM: Classification of Malignant Tumours. 6th ed. Wiley & Sons: New York, NY; 2002.
5. Greene LF, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual, Sixth Edition. New York, NY: Springer-Verlag; 2002.
6. Burke AP, Mostofi FK. Placental alkaline phosphatase immunohistochemistry of intratubular malignant germ cells and associated testicular germ cell tumors. Hum Pathol. 1988;19:663-670.
7. Hu LM, Phillipson J, Barsky SH. Intratubular germ cell neoplasia in infantile yolk sac tumor: verification by tandem repeat sequence in situ hybridization. Diag Mol Pathol. 1992;1:118-128.
8. Krabbe S, Skakkebaek NE, Berthelsen JG, et al. High incidence of undetected neoplasia in maldescended testes. Lancet. 1979;1:999-1000.
9. Parkinson MC, Swerdlow AJ, Pike MC. Carcinoma in situ in boys with cryptorchidism: when can it be detected? Br J Urol. 1994;73:431-435.
10. Renedo DE, Trainer TD. Intratubular germ cell neoplasia (ITGCN) with p53 and PCNA expression and adjacent mature teratoma in an infant testis: an immunohistochemical and morphologic study with a review of the literature. Am J Surg Pathol. 1994;18:947-952.
11. Stamp IM, Barlebo H, Rix M, et al. Intratubular germ cell neoplasia in an infantile testis with immature teratoma. Histopathology. 1993;22:69-72.
12. Stamp IM, Jacobsen GK. Infant intratubular germ cell neoplasia. Am J Surg Pathol. 1995;19:489.
13. Burke AP, Mostofi FK. Intratubular malignant germ cells in testicular biopsies: clinical course and identification by staining for placental alkaline phosphatase. Mod Pathol. 1988;1:475-479.
14. Beckstead JH. Alkaline phosphatase histochemistry in human germ cell neoplasms. Am J Surg Pathol. 1983;341-349.
15. Manivel JC, Jessurun J, Wick MR, et al. Placental alkaline phosphatase immunoreactivity in testicular germ-cell neoplasms. Am J Surg Pathol. 1987;11:21-29.
16. Izquierdo MA, van der Valk P, van Ark-Otte J, et al. Differential expression of the c-kit proto-oncogene in germ cell tumours. J Pathol. 1995;177:253-258.
17. Strohmeyer T, Reese D, Press M, et al. Expression of the c-kit protooncogene and its ligand stem cell factor (SCF) in normal and malignant human testicular tissue. J Urol. 1995;153:511-515.
18. Looijenga LH, Stoop H, de Leeuw HP, et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res. 2003;63:2244-2250.
19. Giwercman A, Lindenberg S, Kimber SJ, et al. Monoclonal antibody 43-9F as a sensitive immunohistochemical marker of carcinoma in situ of human testis. Cancer. 1990;65:1135-1142.
20. Heidenreich A, Sesterhenn IA, Mostofi FK, et al. Immunohistochemical expression of monoclonal antibody 43-9F in testicular germ cell tumors. Int J Androl. 1998;21:283-288.
21. Giwercman A, Andrews PW, Jorgensen N, et al. Immunohistochemical expression of embryonal marker TRA-1-60 in carcinoma in situ and germ cell tumors of the testis. Cancer. 1993;72:1308-1314.
22. Andrews PW, Banting G, Damjanov I, et al. Three monoclonal antibodies defining distinct differentiation antigens associated with different high molecular weight polypeptides on the surface of human embryonal carcinoma cells. Hybridoma. 1984;3:347-36.
23. de Graaff WE, Oosterhuis JW, de Jong B, et al. Ploidy of testicular carcinoma in situ. Lab Invest. 1992;66:166-168.
24. el-Naggar AK, Ro JY, McLemore D, et al. DNA ploidy in testicular germ cell neoplasms: histogenetic and clinical implications. Am J Surg Pathol. 1992;16:611-618.
25. Muller J, Skakkebaek NE. Microspectrophotometric DNA measurements of carcinoma in situ germ cells in testis. Int J Androl. 1981;4:211-221.
26. Looijenga LH, Rosenberg C, van Gurp RJ, et al. Comparative genomic hybridization of microdissected samples from different stages in the development of a seminoma and a non-seminoma. J Pathol. 2000;191:187-192.
27. Rodriguez E, Houldsworth J, Reuter VE, et al. Molecular cytogenetic analysis of i(12p)-negative human male germ cell tumors. Genes Chromosomes Cancer. 1993;8:230-236.
28. Rosenberg C, van Gurp RJ, Geelen E, et al. Overrepresentation of the short arm of chromosome 12 is related to invasive growth of human testicular seminomas and nonseminomas. Oncogene. 2000;19:5858-5862.
29. Ulbright TM, Amin MB, Young RH. Atlas of Tumor Pathology: Tumors of the Testis, Adnexa, Spermatic Cord and Scrotum. Washington, DC: Armed Forces Institute of Pathology; 1999.
30. Leroy X, Augusto D, Leteurtre E, et al. CD30 and CD117 (c-kit) used in combination are useful for distinguishing embryonal carcinoma from seminoma. J Histochem Cytochem. 2002;50:283-285.
31. Jones TD, Ulbright TM, Eble JN, et al. OCT4 staining in testicular tumors, a sensitive and specific marker for seminoma and embryonal carcinoma. Am J Surg Pathol. 2004;28:935-940.
32. Zeeman AM, Stoop H, Boter M, et al. VASA is a specific marker for both normal and malignant human germ cells. Lab Invest. 2002;82:159-166.
33. Franke FE, Pauls K, Metzger R, et al. Angiotensin I-converting enzyme and potential substrates in human testis and testicular tumours. APMIS. 2003;111:234-244.
34. Cheville JC, Rao S, Iczkowski KA, et al. Cytokeratin expression in seminoma of the human testis. Am J Clin Pathol. 2000;113:583-588.
35. Tickoo SK, Hutchinson B, Bacik J, et al. Testicular seminoma: a clinicopathologic and immunohistochemical study of 105 cases with special reference to seminomas with atypical features. Int J Surg Pathol. 2002;10:23-32.
36. Thackray AC, Crane WA. Seminoma. In: Pugh RCB, ed. Pathology of the Testis. Blackwell Scientific: Oxford; 1976:164-198.
37. Mostofi FK, Sesterhenn IA, Davis CJ Jr. Immunopathology of germ cell tumors of the testis. Semin Diagn Pathol. 1987;4:320-341.
38. Jacobsen GK, von der Maase H, Specht L. Histopathological features of stage I seminoma treated with orchidectomy only. J Urol Pathol. 1995;3:85-94.
39. Burke AP, Mostofi FK. Spermatocytic seminoma: a clinicopathologic study of 79 cases. J Urol Pathol. 1993;1:21-32.
40. Jacobsen GK, Barlebo H, Olsen J. Testicular germ cell tumors in Denmark 1976-1980: pathology of 1058 consecutive cases. Acta Radiol Oncol. 1984;23:293-347.
41. Satie AP, Rajpert-De Meyts E, Spagnoli GC, et al. The cancer-testis gene, NY-ESO-1, is expressed in normal fetal and adult testes and in spermatocytic seminomas and testicular carcinoma in situ. Lab Invest. 2002;82:775-780.
42. Matoska J, Ondrus D, Hornak M. Metastatic spermatocytic seminoma: a case report with light microscopic, ultrastructural, and immunohistochemical findings. Cancer. 1988;62:1197-1201.
43. Matoska J, Talerman A. Spermatocytic seminoma associated with rhabdomyosarcoma. Am J Clin Pathol. 1990;94:89-95.
44. Mostofi FK, Price EB. Tumors of the Male Genital System. Washington, DC: Armed Forces Institute of Pathology; 1973.
45. True LD, Otis CN, Delprado W, et al. Spermatocytic seminoma of testis with sarcomatous transformation: a report of five cases. Am J Surg Pathol. 1988;12:75-82.
46. Floyd C, Ayala AG, Logothetis CJ, et al. Spermatocytic seminoma with associated sarcoma of the testis. Cancer. 1988;61:409-414.
47. Jacobsen GK, Jacobsen M. Alpha-fetoprotein (AFP) and human chorionic gonadotropin (HCG) in testicular germ cell tumours: a prospective immunohistochemical study. Acta Pathol Microbiol Immunol Scand [A]. 1983;91:165-176.
48. Jacobsen GK, Jacobsen M, Clausen PP. Distribution of tumor-associated antigens in the various histologic components of germ cell tumors of the testis. Am J Surg Pathol. 1981;5:257-266.
49. Pallesen G, Hamilton-Dutoit SJ. Ki-1 (CD30) antigen is regularly expressed by tumor cells of embryonal carcinoma. Am J Pathol. 1988;133:446-450.
50. Mostofi FK, Sesterhenn IA. Pathology of germ cell tumors of testes. Prog Clin Biol Res. 1985;203:1-34.
51. Moul JW, McCarthy WF, Fernandez EB, et al. Percentage of embryonal carcinoma and of vascular invasion predicts pathological stage in clinical stage I nonseminomatous testicular cancer. Cancer Res. 1994;54:362-364.
52. Sesterhenn IA, Weiss RB, Mostofi FK, et al. Prognosis and other clinical correlates of pathologic review in stage I and II testicular carcinoma: a report from the Testicular Cancer Intergroup Study. J Clin Oncol. 1992;10:69-78.
53. Kaplan GW, Cromie WC, Kelalis PP, et al. Prepubertal yolk sac testicular tumors: report of the testicular tumor registry. J Urol. 1988;140:1109-1112.
54. Teilum G. Endodermal sinus tumors of the ovary and testis: comparative morphogenesis of the so-called mesonephroma ovarii (schiller) and extraembryonic (yolk sac-allantoic) structures of the rat placenta. Cancer. 1959;12:1092-1105.
55. Singer G, Kurman RJ, McMaster MT, et al. HLA-G immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as a useful marker in differential diagnosis. Am J Surg Pathol. 2002;26:914-920.
56. Ulbright TM, Young RH, Scully RE. Trophoblastic tumors of the testis other than classic choriocarcinoma: "monophasic" choriocarcinoma and placental site trophoblastic tumor: a report of two cases. Am J Surg Pathol. 1997;21:282-288.
57. Cheng L, Henley JD, Cummings OW, et al. Cystic trophoblastic tumor: a favorable histologic lesion in post-chemotherapy resections of patients with testicular germ cell tumors. Mod Pathol. 2001:14:104A. Abstract.
58. Rushton HG, Belman AB, Sesterhenn I, et al. Testicular sparing surgery for prepubertal teratoma of the testis: a clinical and pathological study. J Urol. 1990;144:726-730.
59. Silver SA, Wiley JM, Perlman EJ. DNA ploidy analysis of pediatric germ cell tumors. Mod Pathol. 1994;7:951-956.
60. Mostert M, Rosenberg C, Stoop H, et al. Comparative genomic and in situ hybridization of germ cell tumors of the infantile testis. Lab Invest. 2000;80:1055-1064.
61. Friedman NB, Moore RA. Tumors of the testis: a report on 922 cases. Milit Surgeon. 1946;99:573-593.
62. Barsky SH. Germ cell tumors of the testis. In: Surgical Pathology of Urology Diseases, Javadpour N, Barsky SH, eds. Baltimore, Md: Williams and Wilkins; 1987.
63. von Hochstetter AR, Hedinger CE. The differential diagnosis of testicular germ cell tumors in theory and practice: a critical analysis of two major systems of classification and review of 389 cases. Virchows Arch A Pathol Anat Histol. 1982;396:247-277.
64. Mostert MC, Verkerk AJ, van de Pol M, et al. Identification of the critical region of 12p over-representation in testicular germ cell tumors of adolescents and adults. Oncogene. 1998;16:2617-2627.
65. Mostert MM, van de Pol M, Olde Weghuis D, et al. Comparative genomic hybridization of germ cell tumors of the adult testis: confirmation of karyotypic findings and identification of a 12p-amplicon. Cancer Genet Cytogenet. 1996;89:146-152.
66. Ulbright TM, Srigley JR. Dermoid cyst of the testis: a study of five postpubertal cases, including a pilomatrixoma-like variant, with evidence supporting its separate classification from mature testicular teratoma. Am J Surg Pathol. 2001;25:788-793.
67. Singh N, Cumming J, Theaker JM. Pure cartilaginous teratoma differentiated of the testis. Histopathology. 1997;30:373-374.
68. Aguirre P, Scully RE. Primitive neuroectodermal tumor of the testis: report of a case. Arch Pathol Lab Med. 1983;107:643-645.
69. Nistal M, Paniagua R. Primary neuroectodermal tumour of the testis. Histopathology. 1985;9:1351-1359.
70. Nocks BN, Dann JA. Primitive neuroectodermal tumor (immature teratoma) of testis. Urology. 1983;22:543-544.
71. Young RH, Scully RE. Testicular Tumors. Chicago, Ill: ASCP Press; 1990.
72. Motzer RJ, Amsterdam A, Prieto V, et al. Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors. J Urol. 1998;159:133-138.
73. Ahmed T, Bosl GJ, Hajdu SI. Teratoma with malignant transformation in germ cell tumors in men. Cancer. 1985;56:860-863.
74. Mostofi FK. Pathology of germ cell tumors of testis: a progress report. Cancer. 1980;45:1735-1754.
75. Lopez JI, Angulo JC. Burned-out tumour of the testis presenting as retroperitoneal choriocarcinoma. Int Urol Nephrol. 1994;26:549-553.
76. Rottinto A, Debellis H. Extragenital chorioma: its relation to teratoid vestiges in the testicles. Arch Pathol. 1944;37:78-80.
77. Azzopardi JG, Mostofi FK, Theiss EA. Lesions of testes observed in certain patients with widespread choriocarcinoma and related tumors: the significance and genesis of hematoxylin-staining bodies in human testis. Am J Pathol. 1961;38:207-225.
78. Donohue JP, Zachary JM, Maynard BR. Distribution of nodal metastases in nonseminomatous testis cancer. J Urol. 1982;128:315-320.
79. Borge N, Fossa SD. Late relapses of testicular cancer: a review. Cancer J. 1990;3:53-55.
80. Roth BJ, Greist A, Kubilis PS, et al. Cisplatin-based combination chemotherapy for disseminated germ cell tumors: long-term follow-up. J Clin Oncol. 1988;6:1239-1247.
81. Freedman LS, Parkinson MC, Jones WG, et al. Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet. 1987;2:294-298.
82. Fung CY, Kalish LA, Brodsky GL, et al. Stage I nonseminomatous germ cell testicular tumor: prediction of metastatic potential by primary histopathology. J Clin Oncol. 1988;6:1467-1473.
83. Mostofi FK. Histological change ostensibly induced by therapy in the metastasis of germ cell tumors of testis. Prog Clin Biol Res. 1985;203:47-60.
84. Blanke CD, Delgalvis SC, Nichols GR. Late recurrence of seminoma. South Med J. 1997;90:653-655.
85. Baniel J, Foster RS, Gonin R, et al. Late relapse of testicular cancer. J Clin Oncol. 1995;13:1170-176.